/wp-content/uploads/logo.png00Andrea Kushner/wp-content/uploads/logo.pngAndrea Kushner2022-08-18 10:05:362022-09-06 10:37:20A phase 2 Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
